Introduction
Mast cell chymase is a potent chymotrypsin-like angiotensin (Ang) II-forming serine proteinase that is mainly produced by mast cells in vessels (1, 2) and in the heart (3) and that can convert big-endothelins to endothelins (1-31) (4). Chymase-dependent Ang II formation has been shown in the intact hamster, where Ang II converting enzyme (ACE) incell (SMC) growth and proliferation, vascular remodeling, and cardiac hypertrophy (6) .
It has been suggested that chymase plays a significant role in cardiovascular diseases (7) . For example, chymase mRNA and activity have been shown to be increased in the human heart after myocardial infarction and formation of atherosclerotic lesions (8, 9) . In addition, chymase inhibitors have been shown to improve the survival rate after myocardial infarction in a hamster experimental model (10, 11) , to significantly decrease atherosclerotic development in hamsters (12) , and to reduce neointima formation in dog vein grafts (13) .
In addition to the Ang II-forming activity (AIIFA) by hchymase, the involvement of mammalian chymase in local inflammation has been suggested by several studies in vitro. Isolated chymase activates a potent proinflammatory cytokine, interleukin (IL)-1β (14) , degrades IL-4 (15) , and cleaves a membrane-bound stem cell factor, provoking its release from cells (16) . Isolated dog chymase is known to enhance histamine-induced vascular leakage in the skin of dogs (17) . Human mast cell chymase also induces neutrophil and eosinophil recruitment in the skin of guinea-pigs as well as in the peritoneum of mice (18) , suggesting a potential role of h-chymase in inflammatory cell migration. The participation of chymase in tissue matrix remodeling is also supported by a number of in vitro studies demonstrating that mammalian chymases activate procolagenase, degrade extracellular matrix (19) , proteolytically liberate matrix-bound transforming growth factor (TGF)-β1 (20) , and process procollagen to form collagen fibrils (21) . However, these results were obtained either by in vitro study or temporary treatment by recombinant or isolated, but not intrinsic, chymases.
Although the chymase selective substrate [Pro 11 ,DAla 12 ]Ang I has been shown to cause a hypertensive reaction in hamsters (5) and baboons (22) , the exact role of h-chymase in hypertension has not been clarified. In the present study, in order to test whether genetic introduction of the hchymase gene causes hypertension or inflammation-related phenotypes, three independent transgenic mice (TGM) lines expressing the h-chymase gene were established and their phenotypes were analyzed .
Methods Preparation of the h-Chymase Transgene
The isolated h-chymase cDNA (23) was subcloned into pCAGGS, a pKCR-3-based plasmid which contains a CMV-IE fragment and it lies upstream of the chicken β actin promoter ( Fig. 1) (24) . The h-chymase sequences were confirmed by the dideoxy sequencing method. The pCAGGS-hchymase plasmid DNA was digested with SalI and KpnI, and the isolated h-chymase transgene fragment was gel-purified and used for microinjection (25) .
Production of Transgenic Mice (TGM)
The C57BL/6 (B6) mouse strain was used to produce h-chymase TGM. Fertilized eggs were collected from the oviducts of superovulated B6 females that had been mated to males of the same genetic background. Several hundred molecules of the h-chymase transgene fragments were microinjected into the fertilized eggs of B6 mice according to the method previously described (26) .
Newborn mice were screened for integration of the transgene by polymerase chain reaction (PCR) of tail DNA (1 ng) with the primers 5 -ACACTCCCCTTCCCATCACAA-3 and 3 -GGGCTTTGCATCCGACCGTC-5 , based on the h-chymase cDNA sequence. PCR was carried out in 1 PCR buffer (50 mmol/l KCl, 1.5 mmol/l MgCl2, 10 mmol/l TrisHCl, pH 8.3), 200 µmol/l dNTP, and 2.5 U of Taq polymerase. After the 30th cycling reaction of 96 ºC for 30 s (denaturing), 58 ºC for 30 s (annealing), and 72 ºC for 1 min (extension), the targeted sequence (297 bp) that is specific to the transgene was amplified. The presence of the transgene was also confirmed by Southern blotting of tail DNA using an hchymase full-length cDNA probe. The inheritance pattern was compatible with a single autosomal integration site. Eight of 75 mice were positive for the h-chymase gene. Their offspring and the TGM and control mice were housed together under condition of controlled light (12 h light/12 h dark) and temperature (23 2 ºC) with free access to food and water. The investigation conformed with the "Guide for the Care and Use of Laboratory Animals" published by the US National Institute of Health (NIH Publication No. 85-23, revised 1996). All animal experiments were approved by our institutional committee and were performed according to its guidelines.
Measurement for Food Consumption
Adult female mice of TGM (n 6) and control (wild type) mice (n 6) were used in this experiment. Daily diet intake was determined by weighing the food remaining in each cage on the next day and replacing it with fresh preweighed diet. Diet intake was calculated by subtracting the weight of the uneaten diet from the preweighed amount added to the cage. Spillage of diet was not measured.
Measurement of Blood Pressure and Rectal Temperature
Blood pressure was measured in both TGM and their control-group littermates at 12 weeks of age. The systolic blood pressure (SBP) was measured by a programmable sphygmomanometer (MK-2000; Muromachi, Tokyo, Japan) using the tail-cuff method. Unanaesthetized mice were introduced into a small holder during measurement at room temperature. The effect of the AT1 receptor antagonist valsartan (Novartis Pharma, Basal, Switzerland) on blood pressure was also tested. The TGM group was separated into two groups, one that received, one that did not receive valsartan (14 mg/kg/day) in their drinking water. Measurement of the rectum temperature was performed using a Thermaleart TH-5 (Physitemp Instruments Inc., Clifton, USA).
Blood Cell Count
Complete blood cell counting was obtained by retro-orbital venous plexus sampling in polypropylene tubes containing EDTA. The number of blood cells was determined using an automatic cell counter (Celltac, MEK-6158; Nihon Kohden, Tokyo, Japan) and differential counts on zifquiuck stain smears.
Preparation of Total RNA and Blot Hybridization with Chymase Probes
Total RNA was isolated from each tissue of TGM and their non-transgenic littermates by extraction with acid guanidinium thiocyanate, phenol, and chloroform. Total RNA from arterial walls and other tissues was subjected to electrophoresis in a formaldehyde (1%) gel and transferred to a nylon membrane. The filter was hybridized with a probe of the full-length h-chymase cDNA labeled by random primer methods with α 32 P-dCTP.
Immunoblot Analysis
Each tissue (≈50 mg) was homogenized in 20 mmol/l TrisHCl buffer at pH 7.4 and centrifuged at 40,000 g for 20 min. These homogenization and centrifugation steps were repeated twice. The pellet was resuspended in 20 mmol/l Tris-HCl buffer (pH 8.0) containing 2.0 mol/l potassium chloride and 1% Triton X-100 and incubated with gentle shaking at 4 ºC for 1 h. The mixture was centrifuged as described above, and the resultant supernatant was incubated with 50 µl of a soybean trypsin inhibitor immobilizedagarose suspension. After extensive washing with 20 mmol/l Tris-HCl buffer (pH 8.0), chymase bound to the gel was solubilized in 60 µl of a sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample loading buffer at 22 ºC overnight. The solubilized protein in this loading buffer and pure h-chymase were electrophoresed on 14% sodium dodecyl sulfate-polyacrylamide gel, and the proteins were then transferred to a polyvinilidene difluoride microporous membrane using a semidry blotting system. After blocking and washing of the membrane, an anti-h-chymase monoclonal antibody solution (diluted 1:1,000) was added to the membrane and incubated overnight. After washing, a goat antimouse IgG solution (diluted 1:3,000) was added to the membrane, followed by incubation for 1 h at room temperature. The membrane was washed three times and then placed on a piece of Saran Wrap on a level surface. The substrate solution (10 ml of chemiluminescent substrate per 200 cm 2 ) was added to the membrane and incubated for 5 min. The membrane was drained of excess liquid and exposed to X-ray or instant film at room temperature.
Preparation of Tissue Particle Fractions for the Assay of AIIFA
After being thawed and weighed, tissues were dissected into small pieces. They were placed in 50 mmol/l H2PO4 buffer (0.5 g/5 ml), pH 7.4, at 4 ºC and homogenized using a polytron homogenizer (Kinematica GMPH, Cincinnati, USA) at 9,000 rpm for 15 s at 4 ºC. The homogenate was centrifuged at 30,000 g for 20 min at 4 ºC. The supernatants were discarded, the pellets were resuspended in the same buffer, and the homogenization and centrifugation were repeated once. The final tissue pellets were resuspended in 50 mmol/l H2PO4 buffer, pH 7.4, containing 100 mmol/l NaCl and 10 mmol/l MgCl2 using a hand-driven glass/glass homogenizer. The protein concentration of the particulate fraction was measured using Protein Assay Reagent (Pierce, Rockford, USA).
Assessment of Ang II Formation in Particulate Fraction
Assessment of Ang II formation in the tissue particulate fraction of the TGM and control mice was performed according to the method described previously (2) . Briefly, a particulate fraction prepared as described above was incubated with synthetic Ang I (200 µmol/l) with or without inhibitors at 37 ºC for the appropriate time period. The formed Ang II was analyzed by reverse-phase high-performance liquid chromatography (HPLC; Shimadzu, Kyoto, Japan) using a C18 reverse-phase HPLC column (2.2 25 cm; Vydac, Hesperia, USA) with a 15-min linear acetonitrile gradient (3% to 13%) in 25 mmol/l triethylamine-phosphate buffer, pH 3.0, at a flow rate of 2 ml/min. Ang II-forming activities were expressed as nmol of Ang II formed per milligram of protein. Chymostatininhibitable and aprotinin-insensitive Ang II formation were expressed as chymase-dependent Ang II-forming activity. All analyses for each sample were performed in duplicate, and the reproducibility and quality of all data were confirmed before the statistical analysis. The inter-assay and intra-assay coefficients of variation of this assay were 8.6%
(n 12) and 5.1% (n 10), respectively.
Measurement of Plasma Ang I, Ang II, Free T4, and Interleukin (IL)-1
Blood samples from TGM and control mice were collected into ice-cold microcentrifuge tubes containing 1 mmol/l EDTA, which were then immediately centrifuged in order to isolate the plasma fraction. Plasma Ang I and Ang II were measured by the method previously described (27) . In brief, peptides in hamster plasma were extracted by ethanol precipitation and Sep-Pak purification. The residues containing Ang I or II were separated by a C18 reverse-phase HPLC column and the eluting peaks corresponding to orthentic standard Ang I or II were collected to measure each peptide concentration by radioimmunoassay. Thyroid hormones in plasma were measured by a radioimmunoassay (28) . IL-1β in mouse plasma was measured by an immunoassay kit (Bio Source International, Inc., Cmarillo, USA).
Immunohistochemical Studies
For pathological analysis, tissues were fixed with 10% formalin and embedded in paraffin wax, and then sections were stained with hematoxylin and eosin. Each tissue was immunohistochemically stained by the avidin-biotin alkaline phosphatase method. The paraffin-embedded sections were deparaffinized in xylene and dehydrated in graded series of ethanol solutions. Sections were then rinsed 3 times with a washing solution (50 mmol/l Tris-HCl buffer containing 145 mmol/l NaCl, pH 7.4) for 5 min at room temperature. After sections were incubated for 5 min in a blocking solution containing 10% normal nonimmune serum (horse or goat) from species from which the secondary antibody was obtained, sections were incubated for 1 h with the primary antibody (anti-h-chymase polyclonal antibody 50 µg/ml) at room temperature. After being rinsed with the washing solution, sections were incubated with biotin-labeled secondary antibody (goat anti-rabbit immunoglobulin) for 30 min at room temperature and washed 3 times in the washing solution. Sections were applied to peroxidase-conjugated avidin for 30 min at room temperature. After being rinsed 3 times, sections were incubated in a freshly prepared 0.2 mol/l Tris buffer, pH 8.5, containing 0.5 mmol/l naphthol AS-BI-phosphoric acid, 0.27 mmol/l azotized new fuchsin, and 1 mmol/l levamisole. The staining was observed to be adequate (15 to 30 min). Sections were fixed in 10% buffered formalin for 10 min, counterstained with hematoxylin, and mounted. Negative controls were prepared by replacing the primary antibodies with preimmune rabbit IgG.
Inflammatory cell infiltration was quantitatively evaluated using antisera for leukocyte surface markers-LCA for lymphocytes and CD68 for macrophages (Dako; Dakocytomation A/S, Glostrup, Denmark)-as described above, and by direct cell counting for polymorphonuclear leukocytes. For each section, photomicrographs (100-fold magnification) of 20 randomly selected fields were obtained from the intermediate layers of the myocardium. LCA-positive cells, CD68-positive cells, and polymorphonuclear cells were counted and the number of inflammatory cells per unit area (1 mm 2 ) was calculated.
Statistical Analysis
All values are expressed as the mean SD. Student's t-test was used for the statistical comparison of groups showing normal distribution, and one-way ANOVA was used for groups of unequal distribution. Values of p 0.05 were considered statistically significant. 
Results

Production and Establishment of the TGM Line
Eight lines of TGM were obtained. Two lines of the mice, lines 42 and 69, showed high copy numbers of the transgene, as estimated by Southern blot analysis using the tail DNA (data not shown). Line 69 had the highest copy number of the transgene. In the lines 42 and 69, the homozygous mice were suffered from intrauterine death. Although we established homozygous TGM in line 71, it was difficult to maintain homozygosity due to the low fertility. The heterozygous mice of lines 42 and 69 and the homozygous mice of line 71 showed similar phenotypic changes, as described below. Northern blot analysis using a h-chymase cDNA probe demonstrated that h-chymase mRNA was found in various tissues such as the heart, aorta, muscle, brain, liver, and kidney from TGM (Fig. 2a) . In contrast, mRNA of the transgene was not detectable in any organs from the non-transgenic controls.
Western blot analyses of various tissues showed high levels of h-chymase immunoreactivity in the heart, muscle, stomach, and skin, and low levels in the liver (Fig. 2b) . In addition, the 34-kDa immunoreactive bands corresponded to the molecular size of recombinant h-chymase.
AIIFA in Various Organs of TGM and Wild-Type Mice
Tissue AIIFA levels in vitro were determined in several organs. Aortic and hepatic chymase activities in TGM were significantly higher than those in the control mice (Table 1) .
On the other hand, there was no significant difference in plasma Ang I or II levels between the TGM and control mice (Table 1) .
Immunohistochemical Analyses of h-Chymase in TGM and Wild-Type Mice
Immunohistochemical analysis with anti-h-chymase antibody revealed that the majority of chymase immunoreactivity occurred in regions of the extracellular matrix such as the aortic adventitia and medial elastic fiber (arrows in Fig. 3d) , and the basal membrane of both the bronchus and cerebral choroid plexus (data not shown). On the other hand, in control mice, there were no apparent immunohistochemical signals for h-chymase (Fig. 3a) .
Phenotypic Changes
All phenotypic changes were examined in male and female TGM and there were no significant differences between the sexes in any of these changes except body weight (Table 1) . Therefore, most of the following analyses were performed in female mice.
SBP and Left Ventricular Hypertrophy
SBP of TGM at week 12 was significantly higher than that of the littermate control mice (Fig. 4a, 102 3 vs. 130 3 mmHg, n 8 each, p 0.01), and a significant difference in blood pressure appeared from week 5. In addition, treatment with an Ang II type 1 (AT1) receptor antagonist significantly reduced blood pressure to the level in the wild-type mice
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SBP, systolic blood pressure; dAIIFA, dependent angiotensin II-forming activity; Free T3, active thyroid hormone; n, total number of mouse; p 0.05 vs. control. 
Fig. 3. Representative aortic sections of wild-type (a, c) and h-chymase TGM (b, d) immunohistochemically stained with antih-chymase antisera. Photographs c and d are larger magnifications of a and b, respectively. Arrows in d indicate positive immunoreactivity (red color) in the adventitia, vs. a lack of positive immunoreactivity in wild-type mice (a, c). Bars represent
. Comparison of systolic blood pressure (SBP; a) and the ratio of heart weight to body weight (HW/BW; b). The effects of the AT1 receptor antagonist (ARB) on both parameters were examined in wild-type (Wild) and h-chymase transgenic mice (TGM). Both SBP and HW/BW were significantly elevated in TGM, and treatment with the AT1 receptor antagonist significantly reduced both parameters.
( Fig. 4b, 5 .19 0.19, n 6, p 0.05 vs. TGM and control). Both the inner diameters of the transverse section of myocytes and the cardiac fibrosis area were slightly increased, but these increases were not statistically significant (Table  1) . Inflammatory cell infiltration into the interstitial area of the hearts of TGM was significantly greater than that of the control hearts (Table 1) .
Other phenotypic changes in TGM were emaciation (Fig.  5a ) due to a reduction in skin (Fig. 5b, c) and visceral fat, and oligotrichia (Fig. 5a ). These were common phenotypes in the heterozygous mice with high copy number in either sex. This phenotypic change was therefore used as a positive marker to discriminate TGM from non-TGM.
A significant reduction of body weight was observed at week 4 and thereafter (Fig. 6) . The mean body weight of TGM at week 12 was significantly lower than that of the littermate controls (Table 1) . Daily diet intake in TGM was higher than that of the controls (Table 1 ). There were no significant differences in plasma free active thyroid hormone (T3) levels between TGM and control mice (Table 1) .
Peripheral blood cells with leukocyte sub-populations were quantitated. An approximately1.8-fold elevation of total leukocyte counts in TGM at week 10 was found compared with the littermate controls (Fig. 7, 13,275 1,575 vs. 7,425 1,237/µl 2 , n 6 each, p 0.01). A similar leukocy-
Fig. 5. Macroscopic (a) phenotypic comparison of wild-type (left) and h-chymase TGM (right) and a representative back skin section stained with hematoxylin and eosin of wild-type (b) and h-chymase TGM (c). h-chymase TGM mice at 10 weeks of age had a slightly smaller body size, as well as emaciation and oligotrichia, compared to the wild-type mice. The area set apart by arrows shows the thickness of skin fat. Note that the skin fat was reduced only in TGM (c).
Bars represent 300 µm. tosis was observed in male TGM (data not shown). Similar results were confirmed in three independent TGM lines. Leukocytosis in TGM still existed at week 24 (data not shown).
Fig. 6. Time-course changes in the body weight of wild-type (open circles) and h-chymase TGM (closed circles
The rectal temperature of wild-type mice at week 12 was 37.6 0.1 ºC (n 5) and that of TGM was 38.1 0.1 ºC (n 5, p 0.05).
Discussion
The present study suggested that the transgene expression of h-chymase was associated with basal phenotypic changes such as mild hypertension, cardiac hypertrophy, leukocytosis, higher body temperature, oligotrichia, and emaciation due to reduction of fat tissue. Histological expression of the h-chymase transgene was observed in regions of the extracellular matrix, such as the aortic adventitia, medial elastic fiber, and basal membrane of both the bronchus and cerebral choroid plexus. These histological locations of h-chymase transgene expression were not markedly different from those of native h-chymase expression. In addition, the fact that three independent h-chymase TGM lines showed identical phenotypes suggested that these phenotypic changes were due to the transgene expression.
The hypertension observed in this TGM line was not severe, which is apparently different from Tsukuba Hypertensive Mice carrying the h-renin and angiotensinogen genes (29) . It has been suggested that rat chymase transgenic expression in vascular smooth muscle cells is also associated with a moderate increase of blood pressure (30) . These data potentially suggested that chymase gene expression causes a hypertensive response in vivo irrespective of whether the gene is α (human) or β (rat) chymase. It was important to determine whether this increase in blood pressure is mediated through the AT1 receptor. Our data suggest that the increased blood pressure in TGM in the present study was AT1 receptor-dependent because the increase was completely normalized by simultaneous treatment with an AT1 receptor antagonist. Thus, chymase-dependent Ang II formation contributed to the slight increase in blood pressure in this TGM model.
h-Chymase TGM also showed cardiac hypertrophy. Histological examination of the cardiac sections suggested that both cardiomyocyte hyperplasia and an increase in the fibrotic area contributed to the cardiac hypertrophy. In addition, the increase in blood pressure in TGM was rather mild, but the degree of cardiac hypertrophy was relatively larger and was not proportional to the increase in blood pressure. Further, AT1 receptor antagonist treatment significantly, but not completely, suppressed the cardiac hypertrophy. Therefore, we speculate that the cardiac hypertrophy was not due only to an increase in blood pressure. Since valsartan treatment completely normalized blood pressure, but not cardiac hypertrophy, it seemed that there was an AT1 receptor-independent mechanism which caused cardiac hypertrophy in this TGM line. One of the phenotypic changes of h-chymase TGM was chronic inflammation manifested by leukocytosis, increased body temperature, and emaciation. These inflammatory changes would seem to have been independent of the AT1 receptor, since valsartan did not reverse them (data not shown). In addition, the fact that the inflammatory cell infiltrate in the interstitial area of the heart was significantly increased in the hearts of TGM suggests that inflammatory changes were directly involved in the cardiac hypertrophy. Since IL-β is known to be a chemoattractant for various inflammatory cells (31, 32) and to cause myocyte hypertrophy (33) , it is possible that the increase in IL-1β is related to the AT1 receptor-independent hypertrophic change in the heart.
There was no significant difference in serum Ang II level between the TGM and control mice. The exact reason for this finding was not clear. Histologically, the transgene hchymase expression was located mainly in the interstitial region of each organ, which is similar to the original location of native h-chymase (34) . Therefore, it can be speculated that most of the tissue Ang II formation due to the transgene occurred in the interstitial region. In addition, the gene structure of h-chymase indicates that it is a preproenzyme, and that liberation of both pre-and pro-sequences was essential to yield enzymatic activity. Such processing only occurs in cells containing a processing enzyme such as cathepsin C for h-chymase in their secretory granules (23) . This could be a reason why tissue h-chymase activity was rather low compared to the level of the transgene expression, and why the plasma Ang II levels did not show a significant increase compared to that in wild-type mice.
In gross anatomical examination, we found a significant mass reduction in the dermal and visceral fat tissue of TGM. The amount of food intake in TGM did not decrease-and in fact increased-suggesting that appetite loss was not a cause of the emaciation. Since the thyroid function of TGM was within the normal limit, the weight reduction found in h-chymase TGM was not due to hyperthyroidism. Several phenotypic changes, such as leukocytosis, high body temperature, and increased IL-1β suggested that TGM were complicated with chronic inflammation.
The leukocytosis observed in h-chymase TGM was due to the increase of both mononuclear and polymorphonuclear cell fractions. There was no significant increase in any fraction of peripheral leukocytes. In addition, the histological sections of the bone marrow showed hyperplastic changes in the myelocytic cell fraction, but not in the megakaryocyte or erythroblastic cell fractions (data not shown). Therefore, it was likely that the leukocytosis observed in h-chymase TGM was caused by direct stimulation of both the bone marrow and lymph nodes by a circulating humoral factor. Isolated chymase from mast cells induces neutrophilia and eosinophilia following injection into guinea-pig skin (18) . The substrates upon which chymase may act in vivo to stimulate leukocytosis are not clear. One candidate is IL-lβ, the precursor of which is activated by chymase in vitro (14) . IL-lβ is able to induce the accumulation of eosinophils in rat skin (35) and of neutrophils in rabbit skin (31) , and can prime human neutrophils in vitro (32, 36) . IL-1β is a potent proinflammatory cytokine expressed in a number of cell types, and leukocytosis and pyrexia are typical physical changes caused by increased IL-1β. Therefore, chymase-dependent IL-1β activation appears to have been involved in the leukocytosis and pyrexia observed in h-chymase TGM. Furthermore, since chymase is a potent Ang II-forming enzyme (3), the Ang II produced by chymase may induce expression of the potent eosinophil and monocyte chemoattractant factor (RANTES) (37) , or of the monocyte chemoattractant protein-1 (38) . These alternative proinflammatory pathways by Ang II could be additional stimuli for the inflammatory response observed in h-chymase TGM.
There has been no report describing the association between chymase and hair loss, although mast cells appear to be involved in the hair follicle cycle. Maurer et al. reported that mast cells are involved in regulating the hair follicle transformation from a resting state (telogen) to an active hair-growth state (anagen) and that skin mast cells may play a role in spontaneous hair follicle regression (catagen), which is typically characterized by massive epithelial cell apoptosis (39, 40) . There are also clinical indications that mast cells are involved in the pathogenesis of several forms of hair loss and alopecia in humans. In some forms of scarring alopecias (41, 42) and in androgenetic alopecia (43) , the number of skin mast cells is remarkably increased. These data support the notion that mast cells function as a hair cycle regulator and are involved in the control of hair follicle regression. Pathological examination in the present study revealed that the total number of hair follicles did not differ between h-chymase TGM and control mice (data not shown). Therefore, the oligotrichia appearing in this TGM line seemed to be related to the increased hair follicle turnover. The h-chymase TGM model presented in the present study should provide a new tool for examining the role of h-chymase on hair follicle cycling.
In conclusion, this study established the h-chymase TGM line and provided direct evidence of the pathological role of h-chymase in vivo. Our data also suggested that h-chymase might have been involved in the development of mild hypertension with left ventricular hypertrophy, chronic inflammation, and oligotrichea, and that the former phenotypic change appeared to be AT1 receptor-dependent. However, the actions of h-chymase under a pathophysiological condition have been little investigated. In the future, we would like to address these issues using our transgenic model.
